Navigating the Myasthenia Gravis Treatment Market: Key Developments and Future Prospects
Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. As the medical community continues to innovate and adapt treatment strategies, the … Read More